![Logo for Prothena Corporation plc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F62351-2023-12-22-11-12-47.png&w=256&q=100)
Prothena Corporation Investor Relations Material
Latest events
![Logo for Prothena Corporation plc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F62351-2023-12-22-11-12-47.png&w=128&q=100)
Q4 2023
Prothena Corporation
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Prothena Corporation plc
Access all reports
Prothena Corporation plc is a late-stage clinical biotechnology company focused on the discovery and development of novel therapies for diseases caused by protein dysregulation. The company's portfolio includes a range of investigational humanized antibodies and other therapeutic candidates targeting conditions such as AL amyloidosis, Parkinson's disease, ATTR amyloidosis, and Alzheimer's disease. Prothena's approach leverages insights into the biology of misfolded proteins to develop therapies aimed at changing the course of neurodegenerative and rare peripheral amyloid diseases. The company is headquartered in Dublin, Ireland, and its shares are listed on the Nasdaq.
Key slides for Prothena Corporation plc
![20
2023 Actual vs.](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Fprothena-corporation-plc-q4-2023-c838759046ffb4f0%2F20.png&w=3840&q=75)
![Logo for Prothena Corporation plc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F62351-2023-12-22-11-12-47.png&w=128&q=100)
Q4 2023
Prothena Corporation plc
![21
2024 Financial](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Fprothena-corporation-plc-q4-2023-c838759046ffb4f0%2F21.png&w=3840&q=75)
![Logo for Prothena Corporation plc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F62351-2023-12-22-11-12-47.png&w=128&q=100)
Q4 2023
Prothena Corporation plc
Latest articles
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2Fbbbaafadba%2Fpontis-dackmo_strong-opinions-loosely-held.png&w=3840&q=75)
Strong Opinions, Loosely Held: Pontus Dackmo on Flexibility and Market Psychology
After a two-decade career in finance, Pontus Dackmo co-founded Protean Funds Scandinavia in 2022, where he now serves as CEO and Investment Manager.
4 Sep 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2F7455f6afd1%2Fnovo-nordisk_the-danish-pharmaceutical-titan.png&w=3840&q=75)
Novo Nordisk: The Danish Pharmaceutical Titan Revolutionizing Global Healthcare
Novo Nordisk's rise to becoming Europe's largest company, reshaping global healthcare and Denmark's economy.
5 Sep 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2F5533bee49f%2Fthe-toyota-way.png&w=3840&q=75)
The Toyota Way: Revolutionizing Global Manufacturing
Explore how Toyota's Lean Manufacturing and Kaizen principles revolutionized production and quality, setting global benchmarks for excellence.
2 Sep 2024
Ticker symbol
PRTA
Country
🇺🇸 United States